VAXX Biotech Penny Stock Earnings Play VAXX is a speculative penny biotechnology NASDAQ stock with high volatility. On the 2H chart, it is currently trending up from a swing low
on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm
the bullish bias, VAXX is currently trading above its intermediate-term POC line on the volume profile. This confirms buyers as being in
control. Although this is speculative as are all biotechnology penny stocks, impending earnings as a catalyst has been considered.
Continued development in the vaccine subsector at large may suggest VAXX may have a favorable report to fuel further price action.
VCNX
NVAX Biotechnology Watch Dead Cat Bounce LONGNVAX is fundamentally weak with a shallow pipeline and no products currenly marketed
to fund earnings and so research. On the 15 minute chart , NVAX is seen near to its
demand zone as shown by the Luxalgo indicator. In the meanwhile, the RSI indicator
shows considerable recent strength which is decreased today.
So the question is whether NVAX can dead cat bounce with a potential 20% uptrend
to reach the supply one or if it instead will break support and continue its descent
from a double top April 14-17. I will watch this for the price action to determine
whether to take a long trade or short sell this again. Other " vaccine stocks"
may be in action as well including VBIV, VCNX, VAXX and MRNA.
Vaccinex Stock Analysis - VCNX Stock AnalysisTechnical Analysis,
The best option is to hold as technical analysis suggests to go short while fundamental to go long.
Fundamental Analysis
Vaccinex stock rocketed up more than 200% Friday, propelled by two collaboration deals centered on using the biotech company's antibody discovery platform
NASDAQ:VCNX
